Cision PR Newswire

Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMO

Median OS was extended by 8.5 months compared with platinum-based doublet chemotherapy (25.9 vs 17.4 months), with a 31% reduction in the risk...

Thunes Expands Real-Time Cross-Border Payments to Saudi Arabia

LONDON and RIYADH, Saudi Arabia, Sept. 15, 2025 /PRNewswire/ -- Thunes, the Smart Superhighway to move money around the world, has announced the rollout...

EEF’s Sichuan Panda Conservation and Smart Meteorology Study Tour Post-Event, Sharing Session Inspires Youth on ESG, Conservation, and Cross-Border Collaboration

Sponsored by The Hong Kong Jockey Club, Jointly Organized by Earth Environmental Foundation and Chengdu University of Information Technology HONG KONG, Sept. 15,...

Akeso Announces First Patient Dose in Global Registrational Trial of Cadonilimab (PD-1/CTLA-4) for PD-1 Treatment-Resistant Hepatocellular Carcinoma

HONG KONG, Sept. 15, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in its...

Jointly discovered KAT6i molecule originating from Australian research has initiated Phase 3 in HR+ HER2- Breast Cancer with Pfizer Inc

Australian scientists who discovered how to "turn off" genes that make cancer cells grow are celebrating the next phase of development – with Pfizer's...

New Data, iCARE Study: Hailie® Smartinhaler® Powers Unprecedented Medication Adherence in Patients with COPD and Asthma

Highlights: Up to 235% increase in real-world adherence compared to published norms (20–40%), across ~850 chronic obstructive pulmonary disease (COPD)...